News
.gif?1376593640 "Biosave Filter")
BIOCARTIS LAUNCHES ITS FLAGSHIP MOLECULAR DIAGNOSTICS PLATFORM IDYLLA™
Biocartis
12/09/2014With the launch of Idylla™, Biocartis aims to set a new golden standard in molecular diagnostics. Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices. Mechelen (Belgium), September 12th, 2014 – Biocartis, an innovative molecular diagnostics company, announced today that it has officially launched its flagship...
